Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Pâmela Jóyce Previdelli da ConceiçãoInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0001-8314-6870
Gabriela Miranda AyussoInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0002-6008-634X
Tamara CarvalhoInstitut de Recherche en Infectiologie de Montpellier, Centre National de la Recherche Scientifique (CNRS), 34000 Montpellier, France.
Maria Leticia Duarte LimaInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.
Mikaela Dos Santos MarinhoLaboratory of Antiviral Research, Institute of Biomedical Science, ICBIM/UFU, Uberlândia 38405-302, MG, Brazil.
Fábio Rogério MoraesPhysics Department, São Paulo State University-UNESP, São José do Rio Preto 15385-000, SP, Brazil.ORCID 0000-0002-0425-0352
Paola Elaine Galán-JuradoGrupo de Biología Celular y Molecular de Arbovirus, Departamento de Genómica y Proteómica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá City 0816-02593, Panama.ORCID 0000-0003-0461-6542
José González-SantamaríaGrupo de Biología Celular y Molecular de Arbovirus, Departamento de Genómica y Proteómica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá City 0816-02593, Panama.ORCID 0000-0003-1244-3477
Cíntia BittarLaboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.ORCID 0000-0002-2048-4589
Bo ZhangLaboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.ORCID 0000-0002-8895-3679
Ana Carolina Gomes JardimLaboratory of Antiviral Research, Institute of Biomedical Science, ICBIM/UFU, Uberlândia 38405-302, MG, Brazil.ORCID 0000-0002-6348-7923
Paula RahalInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0001-5693-6148
Marilia Freitas CalmonInstitute of Biosciences, Letters and Exact Sciences, São Paulo State University, São José do Rio Preto 15054-000, SP, Brazil.ORCID 0000-0001-5203-0103
Funding
Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.624276/2021-00Fundação de Amparo à Pesquisa do Estado de São Paulo 22/07092-7Secretaría Nacional de Ciencia, Tecnología e Innovación de Panamá (SENACYT) 020-2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus. · full record | OpenQuestion